Cellular senescence: defining a path forward V Gorgoulis, PD Adams, A Alimonti, DC Bennett, O Bischof, C Bishop, ... Cell 179 (4), 813-827, 2019 | 1959 | 2019 |
Chronic p53-independent p21 expression causes genomic instability by deregulating replication licensing P Galanos, K Vougas, D Walter, A Polyzos, A Maya-Mendoza, ... Nature cell biology 18 (7), 777-789, 2016 | 285 | 2016 |
A deep learning framework for predicting response to therapy in cancer T Sakellaropoulos, K Vougas, S Narang, F Koinis, A Kotsinas, A Polyzos, ... Cell reports 29 (11), 3367-3373. e4, 2019 | 179 | 2019 |
Sleep oxygen desaturation predicts survival in idiopathic pulmonary fibrosis L Kolilekas, E Manali, KA Vlami, P Lyberopoulos, C Triantafillidou, ... Journal of Clinical Sleep Medicine 9 (6), 593-601, 2013 | 157 | 2013 |
Expression profiling meta-analysis of ACE2 and TMPRSS2, the putative anti-inflammatory receptor and priming protease of SARS-CoV-2 in human cells, and identification of … E Gkogkou, G Barnasas, K Vougas, IP Trougakos Redox biology 36, 101615, 2020 | 145 | 2020 |
The DNA damage response and immune signaling alliance: Is it good or bad? Nature decides when and where IS Pateras, S Havaki, X Nikitopoulou, K Vougas, PA Townsend, ... Pharmacology & therapeutics 154, 36-56, 2015 | 144 | 2015 |
Systemic mechanisms and effects of ionizing radiation: A new old paradigm of how the bystanders and distant can become the players Z Nikitaki, IV Mavragani, DA Laskaratou, V Gika, VP Moskvin, ... Seminars in cancer biology 37, 77-95, 2016 | 131 | 2016 |
Functional interplay between the DNA-damage-response kinase ATM and ARF tumour suppressor protein in human cancer G Velimezi, M Liontos, K Vougas, T Roumeliotis, J Bartkova, M Sideridou, ... Nature cell biology 15 (8), 967-977, 2013 | 130 | 2013 |
The proteome profile of the human osteosarcoma U2OS cell line KN Niforou, AK Anagnostopoulos, K Vougas, C Kittas, VG Gorgoulis, ... Cancer genomics & proteomics 5 (1), 63-77, 2008 | 129 | 2008 |
Brain proteome response following whole body exposure of mice to mobile phone or wireless DECT base radiation AF Fragopoulou, A Samara, MH Antonelou, A Xanthopoulou, ... Electromagnetic Biology and Medicine 31 (4), 250-274, 2012 | 111 | 2012 |
Comparative analysis of label-free and 8-Plex iTRAQ approach for quantitative tissue proteomic analysis A Latosinska, K Vougas, M Makridakis, J Klein, W Mullen, M Abbas, ... PloS one 10 (9), e0137048, 2015 | 109 | 2015 |
Machine learning and data mining frameworks for predicting drug response in cancer: An overview and a novel in silico screening process based on association rule mining K Vougas, T Sakellaropoulos, A Kotsinas, GRP Foukas, A Ntargaras, ... Pharmacology & therapeutics 203, 107395, 2019 | 106 | 2019 |
Depression, physical activity, energy consumption, and quality of life in OSA patients before and after CPAP treatment C Diamanti, E Manali, M Ginieri-Coccossis, K Vougas, K Cholidou, ... Sleep and breathing 17, 1159-1168, 2013 | 99 | 2013 |
Determinants of resistance to chemotherapy and ionizing radiation in breast cancer stem cells A Pavlopoulou, Y Oktay, K Vougas, M Louka, CE Vorgias, AG Georgakilas Cancer letters 380 (2), 485-493, 2016 | 87 | 2016 |
Application of proteomics for the identification of differentially expressed protein markers for Down syndrome in maternal plasma A Kolialexi, GT Tsangaris, N Papantoniou, AK Anagnostopoulos, ... Prenatal diagnosis 28 (8), 691-698, 2008 | 84 | 2008 |
Characterization of the human urine proteome by preparative electrophoresis in combination with 2‐DE PG Zerefos, K Vougas, P Dimitraki, S Kossida, A Petrolekas, ... Proteomics 6 (15), 4346-4355, 2006 | 73 | 2006 |
Marked defects in the expression and glycosylation of α2-HS glycoprotein/fetuin-A in plasma from neonates with intrauterine growth restriction: proteomics screening and … PM Karamessinis, A Malamitsi-Puchner, T Boutsikou, M Makridakis, ... Molecular & Cellular Proteomics 7 (3), 591-599, 2008 | 69 | 2008 |
Protein biomarkers distinguish between high-and low-risk pediatric acute lymphoblastic leukemia in a tissue specific manner M Braoudaki, GI Lambrou, K Vougas, K Karamolegou, GT Tsangaris, ... Journal of hematology & oncology 6, 1-20, 2013 | 60 | 2013 |
Modulation of the E2F1-driven cancer cell fate by the DNA damage response machinery and potential novel E2F1 targets in osteosarcomas M Liontos, K Niforou, G Velimezi, K Vougas, K Evangelou, ... The American journal of pathology 175 (1), 376-391, 2009 | 58 | 2009 |
Proteomics reveal rat hippocampal lateral asymmetry A Samara, K Vougas, A Papadopoulou, E Anastasiadou, N Baloyanni, ... Hippocampus 21 (1), 108-119, 2011 | 55 | 2011 |